Rare diseases
Investigational molecules
Locations
23 Academy-Ro, Yeonsu-Gu, 22014
Celltrion Inc. includes type 2 diabetes mellitus within its clinical research portfolio, with interest in treatment strategies for patients who have inadequate glycemic control despite established oral therapy. The sponsor’s work in this area reflects attention to combination approaches involving antihyperglycemic agents and broader management of metabolic disorders.
Its diabetes-focused studies align with ongoing interest in improving treatment options for chronic endocrine and metabolic disease.
Celltrion Inc. runs clinical trials in conditions such as Rheumatoid arthritis, Multiple sclerosis, Plasma cell myeloma refractory, Psoriasis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Poland
BulgariaPolandPoland
CroatiaPolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
